Consult
Log In
Menu
Consult
Log in

by Josh Forsythe, on October 11, 2017

PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today it has launched a complete technology and medical interpretation solution to support Illumina’s TruSight Tumor 170 (TST170). PierianDx will feature TST170 in an upcoming webinar October 12, 2017, at 1 pm EST hosted by GenomeWeb.

Read Story
Topics:News

by Josh Forsythe, on September 21, 2017

ST LOUIS  – PierianDx, the forerunner in clinical genomic analysis,
interpretation and reporting, announced that its leading, integrated “one space” genomics
workflow and analysis solution, Clinical Genomicist Workspace (CGW), now supports clinical
microarray (CMA) technology.

Read Story
Topics:News

by Josh Forsythe, on September 11, 2017

PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, will host a webinar featuring Moffitt Cancer Center’s journey to design a world-class precision medicine program.

Read Story
Topics:News

by Josh Forsythe, on March 23, 2017

New Service Combines Powerful Technology with Medical and Scientific Expertise

PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today at annual ACMG Clinical Genetics Meeting in Phoenix that it has launched clinical interpretation services as a part of its entire Next Generation Sequencing (NGS) service portfolio. The new service represents PierianDx’s continued promise to be the “One Space” genomic solution platform with comprehensive service and support for both constitutional and somatic testing.

Read Story
Topics:News

by Josh Forsythe, on March 13, 2017

NEW YORK (GenomeWeb) – Last week, PierianDx announced six new customers for its Clinical Genomicist Workspace (CGW), including Cedars-Sinai Medical Center, Dartmouth-Hitchcock Medical Center, Florida Hospital, Georgia Esoteric & Molecular Laboratory at Augusta University, NorthShore University HealthSystem, and the University of Arkansas for Medical Sciences.

Read Story
Topics:News

by Josh Forsythe, on March 3, 2017

PierianDx announced today that six leading healthcare systems and academic medical centers have chosen its leading “One Space” genomics software solution, CGW, to streamline clinical lab workflow, analysis, interpretation and reporting. More than 40 members of the PierianDx Partner Sharing Network utilize the shared constitutional and somatic genomic data within CGW to target patient-specific diagnosis and treatments for cancers and hereditary diseases.

Read Story
Topics:News

by Josh Forsythe, on February 28, 2017

PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today its latest online webinar entitled, “Accelerating Your NGS Testing Program with Clinical Integration: A Case Study” on March 9 presented by Dr. Nikoletta Sidiropoulos from University of Vermont Medical Center.

Read Story
Topics:News

by Josh Forsythe, on December 6, 2016

Not long ago, doctors hoping to cure human disease spent a lot of time in the laboratory looking through microscopes. But big data has changed all that. Now, many physician scientists spend a lot more time in front of the computer analyzing large datasets which have fundamentally changed how they find cancer treatments. We asked Dr. Rakesh Nagarajan, director of the Institute of Clinical and Translational Sciences Biomedical Informatics Program at Washington University, about how drastic this change is, what the barriers are, and when we might realize the full potential of precision medicine for cancer prevention and treatments.

Read Story
Topics:News

by Josh Forsythe, on October 11, 2016

Company Extends Ability to Deliver a Unified Sample-to-Report Software Platform for Clinical Labs

PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced today the acquisition of Tute Genomics, a genomics software company based in Provo, UT.

Read Story
Topics:News

by Josh Forsythe, on August 30, 2016

ST LOUIS – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, was recently included in a list of the 20 Most Promising Cloud Solutions Providers by CIOReview Magazine.

Read Story
Topics:News

by Josh Forsythe, on July 19, 2016

ST LOUIS/BOULDER – ArcherDX and PierianDx today announced co-marketing and licensing agreements that will provide enhanced NGS testing capabilities to clinical labs. Under the terms of the agreement, PierianDx will integrate Archer ® targeted NGS testing pipelines into the PierianDX Clinical mGenomicist Workspace™ (CGW), the leading cloud-based platform that provides clinical labs more streamlined and accurate NGS data analysis, interpretation, and reporting.

Read Story
Topics:News

by Josh Forsythe, on April 28, 2016

ST. LOUIS, MO  – PierianDx, the forerunner in clinical genomic analysis, interpretation and reporting, announced it has added several new customers in the first quarter of 2016. The new customers include leading health systems, academic medical centers, children’s hospitals, and commercial labs in the U.S. and around the world.

Read Story
Topics:News